The North Face founder has joined the advisory board of the IV therapies specialist
Kenneth “Hap” Klopp is also a lecturer and motivational speaker in strategy, brand building, M&A and financing
Kenneth “Hap” Klopp, the founder and 20-year-CEO of The North Face, has joined REVIV, the global brand in preventative health offering IV therapies and genetics services with a unique holistic wellness approach.
An expert and consultant in marketing strategy and global business, Klopp will serve as Non-Executive Director. He is REVIV's newest member of its advisory board, effective September 1.
“Hap’s coming on board represents a seismic jump for REVIV,” said Sarah Lomas, REVIV President. “His widespread knowledge and groundbreaking methods place REVIV at the perfect juncture to move from IV therapy to overall wellness based on disruptive and groundbreaking genetic analysis.”
Klopp runs a private consulting company, HK Consulting, that specialises in strategy, global business, marketing and sales for sports, apparel and financial services companies.
He is a Board member of numerous business ventures and the author of Conquering The North Face: An adventure in Leadership, and ALMOST: 12 electric months chasing a Silicon Valley Dream.
Klopp is also a lecturer and motivational speaker specialising in strategy, brand building, M&A and financing.
REVIV is a major disruptor in the DNA testing industry. Its depth and excellence will make it the new standard that delivers the triple bottom line: profits, environmental health and societal improvement
“REVIV is a major disruptor in the DNA testing industry,” Klopp said, noting that the company’s depth and excellence “will make it the new standard that delivers the triple bottom line: profits, environmental health and societal improvement”.
Following the appointment, REVIV said the company will undertake Series Round A funding and that Klopp will be contributing his extensive entrepreneurial experience to facilitate the financing.
In September 2019, the company introduced REVIV Genetics, the new disruptive lifestyle genetics service to perfectly complement its overall wellness and preventative health strategy.
REVIV Genetics is deemed the most accurate DNA testing available today at 99.97% accuracy. While currently the only company to provide personal follow-up consultation, REVIV is branching out to offer DNA testing and fully personalised IV therapies designed to maximise overall individual health.
Today, REVIV operates across six continents, with clinics located in over 35 countries, firmly establishing itself as the global market leader in IV therapy-led preventative health solutions.
REVIV Genetics is known to be the most comprehensive analysis available on the market today, providing bespoke health and wellness therapy at its highest accuracy via a very safe and secure doctor-led service.